Clinical trial
Study of Methotrexate in Lupus Erythematosus
NCT00470522 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00470522 |
|---|---|
| Title | Study of Methotrexate in Lupus Erythematosus |
| Official title | A Canadian Multicenter, Randomized, Double-Blind Placebo-Controlled Study of Methotrexate and Folic Acid in Systemic Lupus Erythematosus: A Phase III Trial. |
| Acronym | SMILE |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Methotrexate and folic acid |
| Enrollment | 86 |
| Start date | Jun 1, 1995 |
| Completion | Dec 1, 2001 |
| First posted | May 7, 2007 |
| Last update posted | May 7, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: